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 Fig.  S1. A: Mechanical stimulation of HUVEC with a carbon fibre microelectrode induces WPB exocytosis. The response of 
endothelial cells to mechanical stimulation has been extensively studied, with mechanical pressure, changes in shear stress or 
endothelial cell stretching inducing increases in [Ca2+]i (Demer et al., 1993; Diamond et al., 1994; Goligorsky, 1988; Sigurdson et al., 
1993). The mechanisms underlying the Ca2+ increase are thought to involve both activation of cell surface cation cannels and release 
of intracellular Ca2+ (Mendoza et al., 2010; Nilius et al., 2003). Despite these findings, including the observation that mechanical 
stretch induces VWF release (Galbusera et al., 1997), a direct analysis of WPB exocytosis following mechanical stimulation has 
not been reported. (Ai) shows a representative 355/380nm fura-2 fluorescence record in single proregion-EGFP expressing HUVEC 
during mechanical (grey trace) or histamine (100 µM, black trace) stimulation. (Aii) Cumulative plots of WPB fusion times, 
normalised by the total number, for mechanical (grey traces, 1087 events, 20 cells) or histamine (black traces, 836 events, 26 cells) 
stimulation. (Aiii) mean (± SEM) delay between the [Ca2+]i rise and the first fusion event (s); mean maximal rate of exocytosis (WPBs 
s-1) and the probability of WPB exocytosis (Pr, percent, note broken y axis) for histamine (black bars, n = 26 cells) and mechanical 
(grey bars, n = 20 cells) stimulation. Together the data show that mechanical stimulation results in a rapid release of WPBs with 
a probability of release (Pr) (see (Bierings et al., 2012)), similar to that obtained for a maximal concentration of the physiological 
stimulus histamine.  B: WPB exocytosis is not associated with current spikes. (Bi) Image of an electrode positioned over a region of a 
HUVEC containing multiple fluorescent WPBs (fluorescence intensity changes due to fusion for the three WPBs indicated are plotted 
in (Biv)). Scale bar is 5 µm. (Bii) Fura-2 ratio increase following mechanical stimulation. (Biii) Electrode current recorded at +700 
mV. (Biv) WPB fluorescence intensity of the three WPBs indicated in (Bi). Fluorescence intensity increases are due to fusion of the 
WPBs with the plasma membrane. C: RT-PCR analysis reveals VMAT1 expression in HUVEC. (Left) Three sets of diagnostic primers 
to VMAT1 were tested on HUVEC RNA, with BON cell RNA as a positive control. The identity of the PCR products amplified with 
VMAT1 primers was confirmed by sequencing. (Middle) Primers to VMAT2 and SERT were tested on HUVEC RNA and human 
adrenal RNA, no band of the correct size was observed for either SERT or VMAT2. (Right) Diagnostic primers to PMAT and OCT3 
were tested on HUVEC RNA, with brain RNA as a positive control. No band was observed for OCT3 in HUVEC RNA. Identity of the 
PCR product amplified with PMAT primers was confirmed by sequencing. Lanes marked control contained no template RNA.
Fig.S2. A: EGFP-VAChT localises to WPBs but does not result in WPB-5-HT-IR. Images show a HUVEC 48 hours post-transfection 
with EGFP-VAChT, fixed and immunolabelled for endogenous VWF (blue, rabbit Ab), 5-HT (red) and GFP (green).  Scale bar is 
10 μm.  Gray scale images for each channel, taken from the region indicated by white box, are shown below on an expanded scale. 
B: Reserpine abolishes WPB-5-HT-IR in EGFP-VMAT1 expressing HUVEC. EGFP-VMAT1 expressing HUVEC (48 hours post-
transfection) were treated with (Bi) or without (Bii) 100 µM reserpine for 60 minutes in full growth media. Cells were fixed and 
immunolabelled for VWF (blue, rabbit Ab), 5-HT (red) and EGFP (green). Gray scale images for each channel, taken from the region 
indicated by the white box, are shown below. Scale bars are 50 µm. C: Expression of mCherry-VMAT1 does not alter intra-WPB pH. 
HUVEC were nucleofected with proregion-mEGFP (Proregion), proregion-mEGFP and P-selectin-mCherry (P-selectin, as a control 
for the double transfection) or proregion-mEGFP and mCherry-VMAT1 (VMAT1) and the intra-WPB pH determined by the NH4Cl 
pulse technique using intra-WPB EGFP (fused to proregion) as the WPB-specific pH indicator, as previously described (Erent et al., 
2007). The pH of 20 WPBs was calculated from four cells for each condition. Data expressed as mean ± SD. 
Fig. S3. A: Foetal calf serum is the source for WPB-5-HT-IR in EGFP-VMAT1 expressing HUVEC. Images show EGFP-VMAT1 
expressing HUVEC (16 hours post-transfection) immunolabelled for VWF (left, rabbit Ab), GFP (middle) and 5-HT (right). Cells 
were exposed to 10 mM NH4Cl for 30 minutes to discharge endogenous 5-HT-IR from WPBs, then incubated in full growth media 
(FGM), dialysed media (DM) or serum free growth media (SFGM) (see Materials & Methods) for 5 hours prior to fixation. Scale bars 
are 10 μm. B: Supplementing dialysed media with low concentrations of 5-HT restores WPB-5-HT-IR in EGFP-VMAT1 expressing 
HUVEC. Images show EGFP-VMAT1 expressing HUVEC (16 hours post-transfection) immunolabelled for VWF (left, rabbit Ab), 
GFP (middle) and 5-HT (right). Cells were exposed to 10 mM NH4Cl for 30 minutes to discharge endogenous 5-HT-IR from WPBs, 
then incubated for 5 hours in DM supplemented with 5-HT at the concentrations indicated, prior to fixation. Scale bars are 10 μm. C: 
WPB-5-HT-IR is retained for extended periods in EGFP-VMAT1 expressing HUVEC. EGFP-VMAT1 expressing HUVEC (16 hours 
post-transfection) immunolabelled for VWF (blue, rabbit Ab), GFP (green) and 5-HT (red). Cells were exposed to 10 mM NH4Cl for 
30 minutes to discharge endogenous 5-HT-IR from WPBs, then incubated for 5 hours in dialysed media supplemented with 1.0μM 
5-HT, followed by a further 16 hours in dialysed media prior to fixation. Scale bar is 10 μm. Gray scale images for each channel, taken 
from the region indicated by white box, are shown below on an expanded scale. D: WPB spike charge (Q) is correlated with WPB 
length. An important consideration during analysis of current spikes is whether the concentration of oxidisable molecules is constant 
within all granules in the population (Finnegan et al., 1996). To determine if this was the case for WPBs, we assessed whether WPB 
volume and current spike quantal size (Q) were correlated. The main determinant of WPB volume is the organelles length. The figure 
shows a scatter plot of Q against WPB length (n = 38), taken from imaging and amperometry experiments in which individual WPBs 
could be clearly visualised, allowing their lengths to be measured and plotted against the resulting spike Q recorded following fusion. 
We found that WPB length was significantly correlated with Q (p < 0.0001, r2 = 0.47), indicating that the concentration of oxidisable 
molecules within WPBs is essentially constant irrespective of WPB size.
Table S1 
A: Antibodies 
 Species Manufacturer Clone / catalogue number Dilutions used for IF 
5-HT Mouse mAb Abcam ab16007 1:50 
Cav-1 Rabbit pAb BD Transduction Laboratories 610059/60 1:200 
VWF Rabbit pAb DAKO A0082 1:10000 
VWF Sheep pAb Serotec  AHP062 1:10000 
Proregio
n 
Mouse mAb Previously described See (Hewlett et al., 2011) N/A 
Proregio
n 
Rabbit pAb Previously described See (Hewlett et al., 2011) N/A 
GFP Sheep pAb Biogenesis 4745-1051 1:250 
 
B: RT-PCR primers 
 
Target Primer Sequence Amplicon (bp) 
    
VMAT
1 
EC10-f 5’- gtggtggtattcgtcgcttt -3’ 
199 
 EC11-r 5’- ccacggtgttgttgttgaag -3’ 
VMAT
1 
EC12-f 5’- cttcaaaggctgtgatgcaa -3’ 
253 
 EC13-r 5’- gctcgtcctctctcatggtc -3’ 
VMAT
1 
EC14-f 5’- atgggagtgtctacgccatc -3’ 
244 
 EC15-r 5’- ggcttctgggttgcatacat -3’ 
VMAT
2 
EC16]-f 5’- agaccatgtgttcccgaaag -3’ 
126 
 EC17-r 5’- gaagagcacaaagccacctc -3’ 
SERT EC24-f 5’- caccctagtggctgagcttc -3’ 
214 
 EC25-r 5’- cagtgcgagctccatgtaaa -3’ 
PMAT PMAT-fwd2 5’- cgccatctactttgcgatgc -3’ 
552 
 PMAT-rev2 5’- cactaacaggtgcagcagga -3’ 
OTC3 OTC3-fwd3 5’- taaccattgagcgccttgga -3’ 
472 
 OTC3-rev3 5’- aaggtgagagcgggaaactg -3’ 
 
C: Current spike and pre-spike foot signal parameters recorded from 
control and cholesterol depleted or supplemented HUVEC 
Spike parameters Control 
n = 412 
+ 5 mM MβCD 
n = 405 
+ 5 mM MβCD-Chol 
n = 401 
Imax (pA)* 37.67 ± 1.64 51.27 ± 2.42 32.78 ± 1.45 
t1/2 (ms)* 14.98 ± 0.70 11.90 ± 0.64 18.45 ± 0.83 
Q (pC) 0.77 ± 0.04 0.82 ± 0.06 0.86 ± 0.05 
trise (25-75%) (ms)* 3.36 ± 0.16 2.46 ± 0.11 4.27 ± 0.23 
tdecay (25-75%) (ms)* 
Rise rate (pA/ms)* 
16.47 ± 0.87 
17.45 ± 1.29 
13.31 ± 0.81 
28.66 ± 1.90 
20.27 ± 1.01 
11.48 ± 0.84 
 
Pre-spike foot signal 
parameters 
 
n = 303 
 
n = 303 
 
 
n = 301 
 
Ifoot (pA) 
tfoot (ms)* 
Qfoot (fC)* 
 
4.18 ± 0.27 
11.09 ± 17.46 
68.29 ± 6.92 
 
4.18 ± 0.41 
6.55 ± 0.83 
47.60 ± 7.48 
 
3.94 ± 0.23 
13.93 ± 1.34 
91.67 ± 10.24 
Data are expressed as mean ± SEM. * indicates parameters that are 
significantly different between treatment groups as analysed by one-way 
ANOVA. 
